Disease stabilization versus response after bevacizumab treatment in recurrent ovarian cancer: How do we determine clinical efficacy?

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Fuh, KC; Secord, AA; Bevis, KS; Huh, WK; Blansit, K; Rosenfeld, E; Hu, L; Previs, RA; Gardner, AB; Kapp, DS; Chan, JK

Published Date

  • April 2015

Published In

Volume / Issue

  • 137 /

Start / End Page

  • 56 - 56

Published By

International Standard Serial Number (ISSN)

  • 0090-8258

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2015.01.130